Faeth Therapeutics Inc (FTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,599 | 169,418 | 16,596 | 0 | 0 |
| Marketable Securities | 146,899 | N/A | N/A | 0 | 0 |
| Other current assets | 472 | 60 | 2,105 | 0 | 0 |
| TOTAL | $165,613 | $172,785 | $20,076 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 2,111 | 1,655 | 1,266 | N/A | N/A |
| Other Non-Current Assets | 0 | 36 | 86 | 0 | 0 |
| TOTAL | $2,111 | $1,691 | $1,352 | $N/A | $N/A |
| Total Assets | $167,724 | $174,476 | $21,428 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,828 | 2,002 | 3,882 | 0 | 0 |
| Other current liabilities | 1,095 | 473 | 916 | 0 | 0 |
| TOTAL | $3,923 | $2,475 | $4,830 | $0 | $0 |
| Non-Current Liabilities | |||||
| Long Term Debt | 567 | 567 | 567 | 0 | 0 |
| Other Non-Current Liabilities | 109 | 182 | 72,388 | 0 | 0 |
| TOTAL | $676 | $749 | $73,041 | $N/A | $N/A |
| Total Liabilities | $4,599 | $3,224 | $77,871 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,529 | 1,529 | N/A | N/A | N/A |
| Common Shares | 3 | 3 | N/A | 0 | 0 |
| Retained earnings | -130,155 | -120,384 | -112,412 | 0 | 0 |
| Other shareholders' equity | -101 | 0 | 0 | 0 | 0 |
| TOTAL | $163,125 | $171,252 | $-56,443 | $0 | $0 |
| Total Liabilities And Equity | $167,724 | $174,476 | $21,428 | $0 | $0 |